The Food and Drug Administration withdrew its emergency use authorizations the two antiviral drugs promoted by President Trump, despite concerns surrounding their effectiveness and safety.
The FDA has approved the very first treatment for COVID-19, and the drugmaker has donated their “entire supply.”
The drug President Trump has often touted as a treatment for COVID-19, despite it being, as yet, unproven, is set to begin a Phase III clinical trial.
Executives from some of the world’s largest pharmaceutical and biotechnology companies met with President Trump to discuss the timeline of a coronavirus vaccine.
Headlines proclaimed a potential game changer in treating cardiovascular disease—Vascepa—and company shares quickly soared, but the study behind the claim remains a mystery.